SCHEMBL10679197

SCHEMBL10679197

Cc1ccc(C2=C3C=CC(=N3)C(c3ccc(C)cc3C(=O)O)=C3C=CC(=N3)C(c3ccc(C)cc3C(=O)O)=C3C=CC(=N3)C(c3ccc(C)cc3C(=O)O)=C3C=CC2=N3)c(C(=O)O)c1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CSNK2A1 P68400 1/20 0.45
▸ MEN1 O00255 3/20 0.42
▸ KMT2A Q03164 3/20 0.42
▸ ALDH1A1 P00352 2/20 0.39
▸ POLB P06746 1/20 0.38
▸ KDM4E B2RXH2 1/20 0.38
▸ HSD17B10 Q99714 1/20 0.38
▸ NOTUM Q6P988 1/20 0.36
▸ CA9 Q16790 2/20 0.35
▸ CYP46A1 Q9Y6A2 1/20 0.35
▸ ALPL P05186 1/20 0.35
▸ GFER P55789 1/20 0.35
▸ SORT1 Q99523 1/20 0.35
▸ CA12 O43570 2/20 0.35
▸ CA1 P00915 2/20 0.35
▸ CA4 P22748 2/20 0.35
▸ CA7 P43166 2/20 0.35
▸ PIN1 Q13526 1/20 0.35
▸ METAP2 P50579 1/20 0.35
▸ DHODH Q02127 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10681393 0.92 KDM4E (0.44) CSNK2A1MEN1KMT2AALDH1A1POLB
SCHEMBL9391411 0.79 KMT2A (0.48) MEN1KMT2AALDH1A1POLBKDM4E
SCHEMBL935295 0.78 FABP3 (0.44) ALDH1A1POLBKDM4EHSD17B10CA9
SCHEMBL4621112 0.76 CSNK2A1 (0.65) CSNK2A1MEN1KMT2AALDH1A1POLB
SCHEMBL1977054 0.71 ALDH1A1 (0.53) MEN1KMT2AALDH1A1POLBKDM4E
SCHEMBL18116578 0.70 CSNK2A1 (0.57) CSNK2A1MEN1KMT2AALDH1A1POLB
SCHEMBL6495696 0.70 HSD17B10 (0.58) CSNK2A1MEN1KMT2AALDH1A1POLB
SCHEMBL223101 0.68 CSNK2A1 (0.65) CSNK2A1MEN1KMT2AALDH1A1KDM4E
SCHEMBL31517191 0.68 CSNK2A1 (0.54) CSNK2A1MEN1KMT2AALDH1A1POLB
SCHEMBL3733709 0.68 HDAC7 (0.60) CSNK2A1ALDH1A1POLBKDM4EHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11135310-B2 Gold porphyrin-PEG conjugates and methods of use THE UNIVERSITY OF HONG KONG (HK) 2021-10-05 — — US disclosed
EP-3386986-B1 GOLD PORPHYRIN-PEG CONJUGATES AND METHODS OF USE UNIV HONG KONG (CN) 2021-07-21 — — EP disclosed
US-20170157261-A1 GOLD PORPHYRIN-PEG CONJUGATES AND METHODS OF USE THE UNIVERSITY OF HONG KONG (HK) 2017-06-08 — — US disclosed
US-4783529-A Rapid synthesis of radiolabeled porphyrin complexes for medical application RESEARCH CORPORATION TECHNOLOGIES (US) 1988-11-08 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11135310-B2 Gold porphyrin-PEG conjugates and methods of use HCCS, PPOX, LIG3 CSNK2A1 3988/4885MEN1 3439/4885KMT2A 4420/4885
US-20170157261-A1 GOLD PORPHYRIN-PEG CONJUGATES AND METHODS OF USE HCCS, PPOX, LIG3 CSNK2A1 3988/4885MEN1 3439/4885KMT2A 4420/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback